newswire, breaking biotechnology and pharma news

Thursday, September 13, 2012

Biotech Trading Alert: Sunshine Biopharma (OTCBB: SBFM) Shares Move Following News of Advancing to Next Phase of Drug Development with Lead Anti-Cancer Compound, Adva-27a

New York, New York - September 13, 2012 ( Newswire,, an investor research portal specializing in sector research including biotech and pharma stocks issues a trading alert and chart for Sunshine Biopharma Inc. (OTCBB: SBFM). The stock is trading at $0.28, up 0.07 or 33.33% as of 1:55PM EDT on over 121,000 shares.

Sunshine Biopharma announced today an update on progress which has enabled the Company to advance to the next phase of drug development, namely GMP manufacturing, IND-enabling studies and Phase I clinical trials in humans.
"We have made significant recent strides in terms of research results showing the effectiveness of our lead compound against cancer cells as well as in our manufacturing, and recent fund raising efforts," said Dr. Steve N. Slilaty, President and CEO of Sunshine Biopharma.
Read the full news: SBFM/news/2012/ 09131.asp Newswire About Sunshine Biopharma Inc. (OTCBB: SBFM):
Sunshine Biopharma is a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company's lead compound, Adva-27a targets aggressive forms of cancer.
About is a leader in investor stock research by sector, including biotech and pharma stocks. Visit the biotech portal within Investor Ideas:
Follow on Twitter!/Investorideas
Follow on Facebook
Sign up for the free investor news and biotech stock alerts
Disclaimer/ Disclosure : The is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: A third party on behalf of SBFM compensated for news release publishing and distribution: one hundred thousand 144 shares for three months starting June 26 th
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:
800-665-0411 - Source -

No comments:

Post a Comment